小容量血液稀释加自血光亮子治疗高粘滞血症疗效观察

小容量血液稀释加自血光亮子治疗高粘滞血症疗效观察总后西安军工医院（７１００７７）王馥本文采用小容量血液稀释加自血光亮于治疗３０例高粘滞血症，其疗效优于低右对照组，现予报道．资料与方法一、治疗组：３０例均系脑梗塞并高粘滞血症，其中男２４例，女６例，年龄...     

自血光量子治疗急性病毒性肝炎高胆红素血症的退黄观察

自血光量子治疗急性病毒性肝炎高胆红素血症的退黄观察申纪轩，李清甫自血光量子疗法又称紫外线照射充氧自血回输疗法（ＵＢＩ），我院自１９９０年６月至１９９５年８月对急性病毒性肝炎中深度高胆红素血症（ＢＩＬ≥６８．４μｍｏｌ／ｌ）９６例用ＵＢＩ治疗５２例，与...     

肺气肿光量子疗法后血液流变学分析

５２例肺气肿患者经自体血光量子治疗后，血粘度降低，纤维蛋白原及血胆固醇含量皆显著减少，临床症状也有显著改善，说明光量子疗法可矫正肺气肿高粘滞血症，改善症状。     

肺气肿光量子疗法后血液流变学分析

52例肺气肿患者经自体血光量子治疗后，血粘度降低，纤维蛋白原及血胆固醇含量皆显著减少（P＜0．01），临床症状也有显著改善，说明光量子疗法可矫正肺气肿高粘滞血症，改善症状。     

光量子血氧疗法治疗肺心病继发高粘血症30例临床分析

光量子血氧疗法治疗肺心病继发高粘血症３０例临床分析杜忠芳，吴晓丽（吉林省邮电医院１３００２１）赵艳华（黑龙江省汤原县中心医院１５４７００）我们在１９９３年５月至１９９４年１０月期间，对肺心病继发高粘血症３０例行光量子血氧疗法治疗，并与单纯的对症治疗进...     

自血光量子疗法治疗糖尿病脑梗塞30例临床分析

自血光量子疗法治疗糖尿病脑梗塞３０例临床分析金湖县人民医院袁玫关键词光量子疗法；脑梗塞；血液粘度中图号Ｒ５８７．２糖尿病（ＤＭ）并发老年人脑梗塞临床上多见。我院开展自血光量子疗法治疗脑血管病已５年，其中ＤＭ并发脑梗塞并经ＣＴ证实的３０例疗效满意，报告...     

自血光量子疗法治疗脑梗塞30例疗效观察

自血光量子疗法治疗脑梗塞３０例疗效观察（０６７２０３）兴隆矿务局汪庄矿医院李忠（０６７２０４）兴隆矿务局马圈子矿医院任民强自１９９５年１月以来，我们采用自血光量子疗法治疗脑梗塞３０例，并与单纯药物治疗作对照进行临床观察，疗效满意。现对其疗效分析如下：...     

充氧自血光量子疗法对OSAS患者高粘血症的近期疗效观察

目的 为探讨充氧自血光量子疗法对OSAS患者高粘血症的近期治疗作用。方法 治疗组和对照组病人均给予经鼻持续气道正压通气(CPAP)治疗,治疗压力随个体不同。治疗组同时用充氧自血光量子疗法治疗,隔日一次,7—10次为一疗程。两组治疗前后测定血液流变学各项指标,结果采用配对t检验进行统计学处理。结果 治疗组在CPAP治疗的基础上加用充氧自血光量子疗法短期内对OSAS患者高粘血症即有显著改善作用(P<0.05),对照组短期内单用CPAP呼吸机治疗对OSAS患者高粘血症改善作用不大(P>0.05)。结论 充氧自血光量子疗法对OSAS患者高粘血症的近期有显著的治疗效果,且无副作用,值得临床推广应用。     

自血光量子疗法治疗急性有机磷中毒54例

自血光量子疗法治疗急性有机磷中毒５４例安徽省利辛县人民医院内科郭玉芹，张锦林近两年来，我科采用自血光量子疗法治疗急性有机磷中毒取得较好疗效，比常规治疗（包括用解磷定注射液治疗）有显著提高，现介绍如下：１临床资料１９９０年６月～１９９２年６月我科收治急...     

自血光量子疗法对脑梗塞患者血液流变学的影响（附42例观察）

自血光量子疗法对脑梗塞患者血液流变学的影响（附４２例观察）方德仁新疆医学院第一附属医院（８３００００）关键词自血光量子疗法，脑梗塞，血液流变自血光量子疗法主要用于各类感染，如败血症、重症肺炎、难愈性创口、骨髓炎、肝炎和低氧血症等，均获良效。近年来发现...     

Value of D-Dimers in patients with acute aortic dissection

Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P ＜ 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (＞0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P ＜0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P ＜ 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.     

Research of combined liver-kidney transplantation model in rats

Objective： To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods： SD rats served as both donors and recipients. 4℃ sodium lactate Ringer＇s was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava （IVC） inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results： Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion： This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

BLOOD PRESSURE CHANGE WITH AGE IN SALT-SENSITIVE TEENAGERS

Objective To observe blood pressure change with age in salt-sensitive teenagers whose salt sensitivity were determined by repeated testing.Methods Salt sensitivity was determined through intravenous infusion of normal saline combined with volume-depletion by oral diuretic furosemide in 55 teenagers. After five years, salt sensitivity was re-examined and subject blood pressure was followed up. Blood pressure changes in salt-sensitive teenagers were compared to that of non-salt sensitive teenagers over five years.Results After 5 years, the repetition rate of salt sensitivity determined by intravenous saline loading is 92.7%. In teenagers with salt sensitivity on the baseline, both the systolic blood pressure increments and increment rates were much higher than non-salt sensitive teenagers (12.7±12.1 mmHg vs. 2.8±5.2 mmHg, P＜ 0.01; 12.2%± 12.0% vs. 2.5% ±4.4%, P＜ 0.001,respectively). There was a similar trend for diastolic blood pressure (8.4 ± 6.4 mmHg vs. 3.7 ± 6.4 mmHg, P = 0.052; 13.2% ±10.6 % vs. 6.8%± 10.1%, P = 0.053, respectively).Conclusions Salt sensitivity determined by intravenous saline loading showed good reproducibility. Blood pressure increments with age were much higher in salt-sensitive teenagers than non-salt sensitive teenagers, especially in terms of systolic blood pressure.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

Luo Lingjie's Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Dr.Zhang Ren's Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

安心颗粒对急诊经皮冠状动脉介入术后生活质量影响的研究

目的：评价使用安心颗粒对急诊经皮冠状动脉介入术（PPCI）术后生活质量的影响.方法：将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组（术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次）和对照组（仅接受基础药物治疗）.所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表（MIDAS）、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果：入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异（P＞0.05）;出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低（P＜0.05）;组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低（P＜0.05）.两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血（P＞0.05）.两组发生轻度血小板减少症的患者数比较无差异（P＞0.05）.结论：PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.     

The comparative studies of the influences of Urapidil and Nicardipine on sino-atrial node function, atrio-ventricular node function and hemodynamics

Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P＜0.01);the MAP decreased(P＜0.01)and the HR increased drastically(P＜0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.